XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization and Business Operations - Additional Details (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 21, 2022
Jan. 28, 2021
Jan. 28, 2021
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Jul. 29, 2022
Dec. 31, 2021
Subsidiary Sale Of Stock [Line Items]                
Proceeds from issuance of private placement warrants           $ 5,738,000    
Transaction costs       $ 3,622,500 $ 3,622,500      
Business acquisition related costs       1,061,968 1,061,968      
Sea Star Medical Inc                
Subsidiary Sale Of Stock [Line Items]                
Aggregate consideration payable $ 85,000,000              
Common stock, par value $ 0.0001              
Business acquisition, common stock par value $ 10.00              
Business acquisition transaction costs capped amount $ 800,000              
Business acquisition transaction costs capped amount unrestricted cash 15,000,000              
Net tangible assets $ 5,000,001              
Business acquisition related costs       $ 1,100,000 $ 1,100,000      
Sea Star Medical Inc | Subsequent Event [Member]                
Subsidiary Sale Of Stock [Line Items]                
Business acquisition deposit in trust account             $ 1,035,000  
Class A Common Stock [Member]                
Subsidiary Sale Of Stock [Line Items]                
Common stock, par value       $ 0.0001 $ 0.0001     $ 0.0001
IPO [Member]                
Subsidiary Sale Of Stock [Line Items]                
Stock issued     10,350,000          
Sales price per unit   $ 10.00 $ 10.00          
IPO [Member] | Class A Common Stock [Member]                
Subsidiary Sale Of Stock [Line Items]                
Stock issued     10,350,000          
Sales price per unit   10.00 $ 10.00          
Gross proceeds from issuance     $ 103,500,000          
Common stock, par value   11.50 $ 11.50          
Private Placement [Member] | Warrant [Member]                
Subsidiary Sale Of Stock [Line Items]                
Stock issued     5,738,000          
Sales price per unit   1.00 $ 1.00          
Proceeds from issuance of private placement warrants     $ 5,738,000          
IPO and Private Placement [Member]                
Subsidiary Sale Of Stock [Line Items]                
Sales price per unit   $ 10.20 $ 10.20          
Transaction costs   $ 6,211,902 $ 6,211,902          
Underwriting discount     2,070,000          
Deferred underwriting fee     3,622,500          
Underwriter compensation     1,000          
Other offering costs     518,402          
Cash available for working capital     974,009          
Proceeds from sale held in trust   105,570,000 $ 105,570,000          
Maximum interest to pay dissolution expenses   $ 100,000